Handmade quality · Free shipping over $75 · Explore the atelier

BI-882370 evodopa In vivo pharmacological characterization of

SKU: 32559185738

4.5
USD100.00 USD122.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 28 - Aug 2

Description

In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A)

Almonertinib (HS-10296) hydrochloride is an orally available

which inhibits fibroblast growth factor receptor (FGFR) signaling by binding to the extracellular FGFR domain without affecting orthosteric FGF binding

is a pan-antagonist of retinoic acid receptors (RARs) with Kd values of 3nM

Indeglitazar shows an EC50 of 0

BI-882370 evodopa In vivo pharmacological characterization ofBI 882370 is a potent and selective RAF kinase inhibitor that binds to the ATP binding site of the kinase positioned in the DFG out (inactive) conformation of the BRAF kinase. BI 882370 (BI 882370) inhibits the oncogenic BRAFV600E mutant, the WT BRAF and CRAF kinases with IC50s of 0. 4, 0. 8, and 0. 6 nM, respectively. BI 882370 also inhibits SRC family kinases. Product information CAS Number: 1392429 79 6 Molecular Weight: 569. 67 Formula:

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products